Home»News»Vygon launches Surfcath, a novel catheter for a smoother administration of surfactant in premature babies with Respiratory Distress Syndrome

Vygon launches Surfcath, a novel catheter for a smoother administration of surfactant in premature babies with Respiratory Distress Syndrome

April 14, 2020

Surfcath is a unique catheter to be used for administering surfactant with the LISA method for preterm babies with Respiratory Distress Syndrome (RDS), a leading cause of death in premature infants.
Surfcath eliminates need for Magill forceps during Less Invasive Surfactant Administration (LISA) method in preterm babies.
The new 20-centimetre long, transparent, semi-rigid SurfCath catheter features a curved distal tip and allows improved manoeuvrability during the placement of the medical device. This shall ensure smoother application and lower risk of injuries in premature babies.

Learn more

IMPORTANT NOTICE

In this sensitive period due to the coronavirus (COVID-19), the health and safety of Vygon’s employees, as well as all of the stakeholders carrying out our activities, is a top priority for us.
Vygon’s goal is to ensure everyone’s protection, whilst maintaining the best levels of service and quick response to our customer’s needs.

As we are acutely aware of our role in the chain of care, we have taken steps to optimize order management.

Recurring scheduled orders will be delivered as usual: we have planned all necessary stock. Exceptional orders (urgent or consisting of very large quantities) are being analyzed in order to best distribute stock amongst all of our customers. As a result, some orders may be fragmented, for the sake of stock control and solidarity. We thank you for your continued support and understanding.

Whilst protecting all of our customers, we will continue to help those who are on the front line fighting this virus: doctors, nurses, all caregivers and, of course, your patients, as we have always done.